Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
1.
Oncogene ; 34(35): 4647-55, 2015 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-25486434

RESUMEN

Somatic mutations in the gene encoding the catalytic subunit of protein phosphatase 6 (Ppp6c) have been identified in malignant melanoma and are thought to function as a driver in B-raf- or N-ras-driven tumorigenesis. To assess the role of Ppp6c in carcinogenesis, we generated skin keratinocyte-specific Ppp6c conditional knockout mice and performed two-stage skin carcinogenesis analysis. Ppp6c deficiency induced papilloma formation with 7,12-dimethylbenz (a) anthracene (DMBA) only, and development of those papillomas was significantly accelerated compared with that seen following DMBA/TPA (12-O-tetradecanoylphorbol 13-acetate) treatment of wild-type mice. NF-κB activation either by tumor necrosis factor (TNF)-α or interleukin (IL)-1ß was enhanced in Ppp6c-deficient keratinocytes. Overall, we conclude that Ppp6c deficiency predisposes mice to skin carcinogenesis initiated by DMBA. This is the first report showing that such deficiency promotes tumor formation in mice.


Asunto(s)
Fosfoproteínas Fosfatasas/genética , Neoplasias Cutáneas/enzimología , 9,10-Dimetil-1,2-benzantraceno , Animales , Carcinogénesis/metabolismo , Células Cultivadas , Queratinocitos/enzimología , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Ratones Transgénicos , FN-kappa B/metabolismo , Fosfoproteínas Fosfatasas/metabolismo , Transducción de Señal , Piel/enzimología , Piel/patología , Neoplasias Cutáneas/inducido químicamente
3.
Oncogene ; 28(5): 752-61, 2009 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-19043453

RESUMEN

Recent studies have demonstrated essential functions for KIF3, a microtubule-directed protein motor, in subcellular transport of several cancer-related proteins, including the beta-catenin-cadherin(s) complex. In this study, we report identification of the protein-phosphatase Dusp26 as a novel regulator of the KIF3 motor. Here we undertake yeast two-hybrid screening and identify Kif3a, a motor subunit of the KIF3 heterotrimeric complex, as a novel Dusp26-binding protein. Co-immunoprecipitation and colocalization experiments revealed that Dusp26 associates not only with Kif3a, but also with Kap3, another subunit of the KIF3 complex. Dephosphorylation experiments in vitro and analysis using mutant forms of Dusp26 in intact cells strongly suggested that Dusp26 is recruited to the KIF3 motor mainly by interaction with Kif3a, and thereby dephosphorylates Kap3. Forced expression of Dusp26, but not its catalytically inactive mutant, promoted distribution of beta-catenin/N-cadherin, an established KIF3 cargo, to cell-cell junction sites, resulting in increased cell-cell adhesiveness. We also showed that Dusp26 mRNA expression was downregulated in human glioblastoma samples. These results suggest previously unidentified functions of Dusp26 in intracellular transport and cell-cell adhesion. Downregulation of Dusp26 may contribute to malignant phenotypes of glioma.


Asunto(s)
Cadherinas/fisiología , Comunicación Celular/fisiología , Fosfatasas de Especificidad Dual/metabolismo , Cinesinas/metabolismo , Fosfatasas de la Proteína Quinasa Activada por Mitógenos/metabolismo , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Neoplasias Encefálicas/enzimología , Neoplasias Encefálicas/genética , Células COS , Cadherinas/metabolismo , Adhesión Celular , Chlorocebus aethiops , Proteínas del Citoesqueleto/metabolismo , Fosfatasas de Especificidad Dual/genética , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Glioma/enzimología , Glioma/genética , Células HeLa , Humanos , Ratones , Fosfatasas de la Proteína Quinasa Activada por Mitógenos/genética , Proteínas Motoras Moleculares/metabolismo , Células 3T3 NIH , Fosforilación , Unión Proteica
4.
Blood ; 98(10): 3030-4, 2001 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-11698287

RESUMEN

Protein tyrosine phosphatase (PTP) epsilon (PTPepsilon) exists as 2 forms generated by alternative promoter usage. It has recently been reported that a cytosolic isoform of PTPepsilon (PTPepsilonC) when over-expressed in murine M1 myeloid cells inhibits interleukin-6 (IL-6)- and leukemia inhibitory factor-induced activation of Janus kinases (JAKs), thereby suppressing STAT3 tyrosine phosphorylation and STAT3 signaling. This study characterizes an inhibitory action of PTPepsilonC on IL-6 signaling and also reveals that PTPepsilonC inhibitory activity is independent of other potential negative regulators, such as SHP-2 and SOCS family proteins. Furthermore, it analyzes the selectivity of PTPepsilonC action toward several cytokines. On IL-6 stimulation, expression of PTPepsilonC-DA, a catalytically inactive mutant of PTPepsilonC, results in an earlier onset of STAT3 tyrosine phosphorylation, suggesting different modes of action between PTPepsilonC and other negative regulators. In addition, the study shows PTPepsilonC-DA enhances activation of STAT1 by IL-6 as well. In terms of specificity to cytokines, over-expressed PTPepsilonC also inhibits IL-10-induced tyrosine phosphorylation of STAT3 in M1 cells, whereas PTPepsilonC does not affect either interferon-beta- and interferon-gamma-induced tyrosine phosphorylation of STATs or expression of STAT transcriptional targets. Among cytokines tested, the inhibitory effect of PTPepsilonC is selective to IL-6- and IL-10-induced JAK-STAT signaling.


Asunto(s)
Proteínas de Unión al ADN/fisiología , Interleucina-10/antagonistas & inhibidores , Interleucina-6/antagonistas & inhibidores , Péptidos y Proteínas de Señalización Intracelular , Isoenzimas/fisiología , Proteínas Tirosina Fosfatasas/fisiología , Proteínas Tirosina Quinasas/fisiología , Proteínas Represoras , Transducción de Señal/efectos de los fármacos , Transactivadores/fisiología , Factores de Transcripción , Células 3T3 , Animales , Proteínas Portadoras/fisiología , Células Cultivadas , Humanos , Interferón beta/farmacología , Interferón gamma/farmacología , Isoenzimas/genética , Janus Quinasa 1 , Ratones , Células Mieloides/citología , Células Mieloides/efectos de los fármacos , Células Mieloides/enzimología , Fosforilación , Procesamiento Proteico-Postraduccional , Proteína Tirosina Fosfatasa no Receptora Tipo 11 , Proteína Tirosina Fosfatasa no Receptora Tipo 6 , Proteínas Tirosina Fosfatasas/genética , Proteínas/fisiología , Proteínas Tirosina Fosfatasas Clase 4 Similares a Receptores , Receptores de Interleucina/efectos de los fármacos , Receptores de Interleucina-10 , Proteínas Recombinantes de Fusión/fisiología , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Proteína 1 Supresora de la Señalización de Citocinas , Proteína 3 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas , TYK2 Quinasa , Transfección
5.
Neuroreport ; 12(7): 1465-8, 2001 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-11388431

RESUMEN

The role of endothelin-1 (ET-1) in the development of experimental autoimmune encephalomyelitis (EAE) was studied by the blocking the action of ET-1 with a receptor antagonist, BQ-123. Intrathecal administration of BQ-123 significantly ameliorated EAE progression at the peak stage of EAE (p<0.05). By immunohistochemistry, ED-1-positive macrophages in EAE lesions were identified as major producers of ET-1, whereas the immunoreactivity of ET-1 on brain cells, such as astrocytes, was dramatically increased in accordance with the progression of EAE. This study points to a putative pro-1nflammatory role for ET-1 in the pathogenesis of EAE. One possible application for the ET-1 receptor antagonist might be helpful in the therapy of autoimmune neurological disorders.


Asunto(s)
Antihipertensivos/farmacología , Enfermedades Desmielinizantes/fisiopatología , Encefalomielitis Autoinmune Experimental/fisiopatología , Antagonistas de los Receptores de Endotelina , Endotelina-1/antagonistas & inhibidores , Péptidos Cíclicos/farmacología , Médula Espinal/efectos de los fármacos , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Astrocitos/patología , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Vasos Sanguíneos/fisiopatología , Enfermedades Desmielinizantes/tratamiento farmacológico , Enfermedades Desmielinizantes/patología , Modelos Animales de Enfermedad , Encefalitis/tratamiento farmacológico , Encefalitis/patología , Encefalitis/fisiopatología , Encefalomielitis Autoinmune Experimental/tratamiento farmacológico , Encefalomielitis Autoinmune Experimental/patología , Endotelina-1/metabolismo , Femenino , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Inyecciones Espinales , Masculino , Degeneración Nerviosa/tratamiento farmacológico , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Ratas , Ratas Endogámicas Lew , Receptores de Endotelina/metabolismo , Médula Espinal/patología , Médula Espinal/fisiopatología , Resultado del Tratamiento
6.
J Clin Immunol ; 21(3): 155-70, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11403222

RESUMEN

Myelin/oligodendrocyte glycoprotein (MOG) is a surface-exposed antigen of myelin and an important target for autoimmune responses which mediate inflammatory demyelination in the central nervous system. Experimentally, MOG induces strong pathogenic T cell responses in many strains of laboratory animals. Immunological studies in humans also identify MOG as a surprisingly prevalent antigenic molecule among the myelin proteins. In addition, the encephalitogenic properties of MOG are linked to the induction of antibody responses which have been demonstrated to directly promote central nervous system demyelination, a hallmark neuropathological feature in disorders such as human multiple sclerosis. Factors responsible for autoimmunity to MOG likely include genetic influences as well as other mechanisms, which are the subject of intense investigation. This article reviews experimental data currently available on specificity and pathogenic roles of T cell and antibody responses against MOG, which have implications relevant to multiple sclerosis and related disorders.


Asunto(s)
Enfermedades Autoinmunes Desmielinizantes SNC/inmunología , Glicoproteína Asociada a Mielina/inmunología , Secuencia de Aminoácidos , Animales , Antígenos de Superficie , Autoanticuerpos/biosíntesis , Autoantígenos , Linfocitos B/inmunología , Enfermedades Autoinmunes Desmielinizantes SNC/etiología , Modelos Animales de Enfermedad , Encefalomielitis Autoinmune Experimental/etiología , Encefalomielitis Autoinmune Experimental/inmunología , Humanos , Ratones , Datos de Secuencia Molecular , Esclerosis Múltiple/etiología , Esclerosis Múltiple/inmunología , Proteínas de la Mielina , Glicoproteína Asociada a Mielina/genética , Glicoproteína Mielina-Oligodendrócito , Primates , Ratas , Homología de Secuencia de Aminoácido , Linfocitos T/inmunología
7.
J Neuroimmunol ; 114(1-2): 40-7, 2001 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11240014

RESUMEN

Autoimmune inflammation in the central nervous system (CNS) is maintained by secretion of a large number of cytokines. To elucidate its molecular mechanisms, we examined the expression and localization of STAT1, STAT3, STAT4 and STAT6 molecules, which are the downstream molecules of the cytokine signal transduction pathway, in the CNS during acute experimental autoimmune encephalomyelitis (EAE) induced in Lewis rats. Western blot analysis demonstrated that STAT1 protein increased gradually till the recovery stage, whereas STAT4 protein showed abrupt increase at the early stage followed by gradual decrease. STAT3 and STAT6 showed stable expression throughout the course of the disease. The kinetics of the phosphorylated form of STAT1 and STAT4 roughly paralleled that of the total protein although the peak of STAT3 phosphorylation was recognized at the preclinical stage. Immunohistochemical examinations revealed that STAT3 and STAT4, but not STAT1 and STAT6, immunoreactivities were mainly expressed in astrocytes and microglia, respectively, and were closely associated with inflammatory lesions. Taken together, these findings suggest that STAT3 and STAT4 play an important role in the formation of, and recovery from, autoimmune inflammation in the CNS.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Encefalomielitis Autoinmune Experimental/inmunología , Médula Espinal/inmunología , Transactivadores/metabolismo , Animales , Western Blotting , Proteínas de Unión al ADN/análisis , Encefalomielitis Autoinmune Experimental/metabolismo , Inmunohistoquímica , Cinética , Fosforilación , Ratas , Ratas Endogámicas Lew , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Factor de Transcripción STAT4 , Factor de Transcripción STAT6 , Médula Espinal/química , Médula Espinal/metabolismo , Transactivadores/análisis , Tirosina/metabolismo
8.
Cancer Lett ; 161(1): 89-95, 2000 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-11078917

RESUMEN

I-2(PP2A)/SET, an inhibitor of protein phosphatase 2A, is supposed to be one of the oncoproteins associated with human myeloid leukemia. The I-2(PP2A)/SET gene expression was observed ubiquitously among all the rat tissues examined, but low in liver. Of interest is that the expression in the rat primary hepatomas and hyperplastic nodules was significantly elevated. The experiments using regenerating livers after partial hepatectomy showed that the expression of I-2(PP2A)/SET mRNA was low at the quiescent hepatocytes, but up-regulated at 12-24 h after partial hepatectomy, which corresponds to the mid G1 to S transition in the cell cycle. These results suggested the importance of I-2(PP2A)/SET in the hepatocarcinogenesis and hepatic cell proliferation.


Asunto(s)
Neoplasias Hepáticas Experimentales/genética , Regeneración Hepática/genética , Proteínas/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Cromosómicas no Histona , ADN Complementario/genética , Proteínas de Unión al ADN , Regulación Neoplásica de la Expresión Génica , Chaperonas de Histonas , Hígado/metabolismo , Hígado/fisiología , Neoplasias Hepáticas Experimentales/metabolismo , Masculino , Ratones , Datos de Secuencia Molecular , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Biosíntesis de Proteínas , Proteína Fosfatasa 2 , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Distribución Tisular , Factores de Transcripción , Regulación hacia Arriba
9.
J Neuroimmunol ; 108(1-2): 171-80, 2000 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-10900351

RESUMEN

This study was undertaken to better understand the role of cytokines in the pathogenesis, especially in the mechanisms of relapse, of experimental autoimmune encephalomyelitis (EAE). For this purpose, we induced acute and chronic relapsing (CR) EAE in DA rats and determined several immunological parameters in rats at various stages of two types of EAE. Histopathological analysis revealed that there was no significant difference in the severity of inflammation in the spinal cord lesions between the two groups. However, demyelination was observed only in rats with CR EAE. Cytokine analysis by competitive PCR demonstrated that levels of TNF-alpha, IL-6 and IL-12 p40 mRNA in the spinal cord at the first attack of CR EAE were significantly higher than those at the peak stage of acute EAE. The mRNA expression of anti-inflammatory cytokines, IL-10 and TGF-beta1, was generally low in both acute EAE and the first attack of CR EAE and upregulated at later stages of CR EAE. These findings suggest that persistent high-level expression of pro-inflammatory cytokines is closely associated with demyelination and relapse of EAE. In contrast, anti-inflammatory cytokines play only a minor role in the relapse.


Asunto(s)
Citocinas/genética , Encefalomielitis Autoinmune Experimental/genética , Encefalomielitis Autoinmune Experimental/patología , Enfermedad Aguda , Secuencia de Aminoácidos , Animales , Enfermedad Crónica , Encefalomielitis Autoinmune Experimental/inmunología , Inflamación/genética , Inflamación/inmunología , Inflamación/patología , Interferón gamma/genética , Interleucinas/genética , Datos de Secuencia Molecular , Proteína Básica de Mielina/química , Proteína Básica de Mielina/inmunología , Fragmentos de Péptidos/química , Fragmentos de Péptidos/inmunología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas , Recurrencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Médula Espinal/metabolismo , Médula Espinal/patología , Factor de Crecimiento Transformador beta/genética , Factor de Necrosis Tumoral alfa/genética
10.
Neurosci Lett ; 289(1): 41-4, 2000 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-10899404

RESUMEN

The expression of pro-apoptotic molecules p53 and Bax in the spinal cord of rats with experimental autoimmune encephalomyelitis (EAE) was examined. Apoptosis was confirmed by the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method. TUNEL (+) apoptotic cells were mainly either ED1 (+) macrophages or T-cells in the parenchyma of EAE. Western blot analysis showed that both p53 and Bax expression significantly (P<0. 01) increased in the spinal cords of EAE rats at the peak stage, and thereafter declined. An immunohistochemical study showed that inflammatory cells (notably T cells) in the parenchyma express p53 and Bax, while brain cells, including neurons and glia, were devoid of nuclear staining for these molecules. The nuclear expression of p53 largely matches apoptotic cells in the parenchyma of EAE. These findings suggest that the pro-apoptotic molecules p53 and Bax may play an important role in eliminating T cells in the parenchyma in EAE.


Asunto(s)
Encefalomielitis Autoinmune Experimental/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Proteínas Proto-Oncogénicas/biosíntesis , Médula Espinal/metabolismo , Proteína p53 Supresora de Tumor/biosíntesis , Animales , Apoptosis , Encefalomielitis Autoinmune Experimental/patología , Femenino , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Masculino , Ratas , Ratas Endogámicas Lew , Proteína X Asociada a bcl-2
11.
J Biol Chem ; 275(36): 28216-21, 2000 Sep 08.
Artículo en Inglés | MEDLINE | ID: mdl-10859312

RESUMEN

We engineered and expressed both a wild-type and mutant cytosolic isoform of PTPepsilon (PTPepsilonC) in murine M1 leukemic cells, which can be induced to growth arrest and monocytic differentiation by interleukin (IL)-6 and leukemia inhibitory factor (LIF). Forced expression of PTPepsilonC inhibited IL-6- and LIF-induced monocytic differentiation and apoptosis in M1 cells, whereas expression of PTPepsilonM, a transmembrane isoform of PTPepsilon, did not. PTPepsilonC expression resulted in lower levels of IL-6-induced tyrosine phosphorylation of Jak1, Tyk2, gp130, and Stat3 compared with parent cells. In M1 transfectants expressing an inactive mutant of PTPepsilonC, both tyrosine phosphorylation and apoptosis induced by IL-6 and LIF were potentiated rather than inhibited. These results suggest an important role for PTPepsilonC in negative regulation of IL-6- and LIF-induced Jak-STAT signaling.


Asunto(s)
Diferenciación Celular/fisiología , Proteínas de Unión al ADN/metabolismo , Inhibidores de Crecimiento/farmacología , Interleucina-6/farmacología , Linfocinas/farmacología , Glicoproteínas de Membrana/metabolismo , Proteínas Tirosina Fosfatasas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Proteínas/metabolismo , Transactivadores/metabolismo , Animales , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Humanos , Isoenzimas/metabolismo , Janus Quinasa 1 , Factor Inhibidor de Leucemia , Leucemia Mieloide Aguda , Proteínas de Membrana de los Lisosomas , Ratones , Monocitos/citología , Monocitos/fisiología , Proteínas Tirosina Fosfatasas Clase 4 Similares a Receptores , Proteínas Recombinantes/farmacología , Factor de Transcripción STAT3 , Transducción de Señal , TYK2 Quinasa , Transfección , Células Tumorales Cultivadas
12.
Acta Neurol Scand ; 101(3): 145-52, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10705935

RESUMEN

OBJECTIVES: Phasic inhibition index (PII) is the rate of the simultaneous occurrence of phasic chin muscle activity (PCMA) and rapid eye movement bursts during rapid-eye-movement sleep (REMS). In naive patients with infantile spasms (IS), the PII value was found to reflect their prognosis. We studied the effects of adrenocorticotropic hormone (ACTH) on REMS components including PII in IS. METHODS: REMS parameters were examined in 18 IS patients before and after ACTH treatment. The effects of corticosteroids (CSs) were examined in 3 patients with congenital adrenal hyperplasia (CAH) and 3 with nephrotic syndrome (NS). RESULTS: ACTH decreased PII and PCMA in IS patients. In CAH patients, physiological doses of CSs corrected the increased intrinsic ACTH level and increased PII. In NS patients, therapeutic doses of CSs suppressed PCMA without affecting PII. CONCLUSION: ACTH suppressed PCMA through CSs, and reduced PII directly. ACTH was hypothesized to eliminate IS through these dual modes of action.


Asunto(s)
Corticoesteroides/farmacología , Corticoesteroides/uso terapéutico , Hormona Adrenocorticotrópica/farmacología , Hormona Adrenocorticotrópica/uso terapéutico , Inhibición Neural/efectos de los fármacos , Sueño REM/efectos de los fármacos , Espasmos Infantiles/tratamiento farmacológico , Adolescente , Glándulas Suprarrenales/patología , Niño , Mentón/inervación , Electromiografía/métodos , Músculos Faciales/inervación , Femenino , Estudios de Seguimiento , Humanos , Hiperplasia/complicaciones , Hiperplasia/congénito , Hiperplasia/patología , Lactante , Masculino , Síndrome Nefrótico/complicaciones , Conducción Nerviosa/efectos de los fármacos , Polisomnografía/métodos , Espasmos Infantiles/complicaciones , Resultado del Tratamiento
13.
J Neuroimmunol ; 104(1): 15-21, 2000 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-10683510

RESUMEN

To elucidate the factor(s) accelerating the autoimmune disease processes, we induced two types of experimental autoimmune encephalomyelitis (EAE), severe and very mild, in F344 rats by immunization with myelin basic protein (MBP) plus pertussis toxin (PT) (PT+) or with MBP alone (PT-) and compared the differences between the two. Immunohistochemical examinations showed that although the nature of inflammation was essentially the same between the two groups, the proportion of Vbeta8.2(+) T cells in the CNS lesion of PT (+) rats was larger than that of PT (-) rats. Cytokine analysis by competitive PCR revealed that IL-10 mRNA in the lymphoid organ was significantly suppressed in the PT(+) group, whereas levels of IFN-gamma,TNF-alpha and TGF-beta mRNA were insignificantly different after PT administration. In addition, T cells taken from PT (+) rats proliferated well in response to MBP, while those from PT (-) rats showed a marginal response to the same antigen. However, this finding does not indicate the switching of non-encephalitogenic to encephalitogenic T cells upon PT administration because PT (-) rats contained encephalitogenic T cells and/or their precursor cells as revealed by adoptive transfer experiments. Taken together, these findings suggest that suppression of IL-10 by PT administration is the major factor contributing to the exacerbation of EAE in PT(+) rats.


Asunto(s)
Encefalomielitis Autoinmune Experimental/inmunología , Toxina del Pertussis , Factores de Virulencia de Bordetella/inmunología , Animales , División Celular , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/patología , Citocinas/metabolismo , Encefalomielitis Autoinmune Experimental/metabolismo , Encefalomielitis Autoinmune Experimental/patología , Cobayas , Inmunización , Inmunohistoquímica , Mediadores de Inflamación/metabolismo , Proteína Básica de Mielina/inmunología , Reacción en Cadena de la Polimerasa , Ratas , Ratas Endogámicas F344 , Linfocitos T/patología
14.
J Neurosci Res ; 59(1): 145-52, 2000 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-10658195

RESUMEN

Experimental autoimmune encephalomyelitis is a disease induced by neuroantigen-reactive T cells bearing particular types of T cell receptor (TCR). Although the nature of TCRs of encephalitogenic T cells has been partially delineated using encephalitogenic T cell clones established in vitro, the entire TCR repertoire formed in situ after immunization with neuroantigen remains unclear. In the present study, we immunized Lewis rats with myelin basic protein (MBP) and its fragment peptides and determined the TCR repertoire of spinal cord T cells formed after the immunization by CDR3 spectra-typing. It was revealed that the oligoclonal expansion of Vbeta2, Vbeta8.2, and Vbeta17 spectratypes was detectable after immunization with guinea pig MBP and its immunodominant epitope, the 68-88 sequence, whereas immunization with a peptide containing a minor epitope induced Vbeta10 expansion. Immunization with rat MBP induced much broader TCR Vbeta expansion (all of the above Vbetas plus Vbeta3). These findings suggest that TCRs activated by immunization with guinea pig MBP used as heteroclitic immunogen recognize autoantigen, rat MBP. Furthermore, the strategy used in this study gives insight into the pathogenesis of autoimmune disease and provides useful information for designing TCR-based immunotherapy.


Asunto(s)
Regiones Determinantes de Complementariedad , Encefalomielitis Autoinmune Experimental/inmunología , Epítopos/inmunología , Proteína Básica de Mielina/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Médula Espinal/inmunología , Linfocitos T/inmunología , Animales , Región Variable de Inmunoglobulina/análisis , Región Variable de Inmunoglobulina/genética , Inmunoterapia , Proteína Básica de Mielina/farmacología , Ratas , Ratas Endogámicas , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología
15.
J Neuroimmunol ; 102(1): 67-72, 2000 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-10626668

RESUMEN

To characterize experimental autoimmune neuritis (EAN)-inducing T cells in more detail, we performed CDR3 spectratyping analysis and found oligoclonal expansion of several Vbeta spectratypes in nerve-infiltrating T cells. Vbeta5 expansion was observed all the stages examined, whereas Vbeta8.2 and Vbeta17 expansion was mainly found at the peak and preclinical stages, respectively. Since Vbeta5 expansion persists throughout the course of the disease, Vbeta5+ T cells are judged to be the main effector cells. Vbeta8.2+ and Vbeta17+ T cells may also be pathogenic but are not the main effectors because expansion of these spectratypes was found at a limited period of time. Sequence analysis revealed that Vbeta5, Vbeta8.2 and Vbeta17 spectratype-derived TCR clones possess their own dominant sequences in the CDR3 region with no homology among the clones. These findings suggest that polyclonally activated T cells are involved in the formation of the nerve lesion. Furthermore, vaccination with Vbeta5 DNA, but not with Vbeta10 DNA, suppressed the development of EAN significantly. Collectively, these findings indicate that determination of autoimmune disease-associated TCR by CDR3 spectratyping provides useful information for designing TCR-based immunotherapy for the disease.


Asunto(s)
Neuritis Autoinmune Experimental/inmunología , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Secuencia de Aminoácidos/genética , Animales , Secuencia de Bases/genética , Datos de Secuencia Molecular , Proteína P2 de Mielina/inmunología , Neuritis Autoinmune Experimental/prevención & control , Fragmentos de Péptidos/inmunología , Ratas , Ratas Endogámicas Lew , Linfocitos T/inmunología , Vacunación , Vacunas de ADN/uso terapéutico
16.
No To Hattatsu ; 32(6): 503-8, 2000 Nov.
Artículo en Japonés | MEDLINE | ID: mdl-11144164

RESUMEN

Clinical symptoms and MR spectroscopic findings were studied on 4 cases of Pelizaeus-Merzbacher disease including 1 autopsy case. Common symptoms were severe mental retardation and spastic tetraplegia. These cases had nystagmus, and one had involuntary athetotic movement. Genetical diagnosis revealed in 2 cases, duplication of proteolipid protein (PLP) and deletion in 1, whereas one case had no abnormality of PLP gene. MRI indicated the reversal of signal intensities on T1- and T2-weighed images, a characteristic finding of PMD MR spectroscopy demonstrated a pattern of NAA in 3 cases. This was specific to PMD because other white matter diseases show a decrease in NAA. In conclusion, MRS was useful to differentiate PMD from other white matter diseases.


Asunto(s)
Ácido Aspártico/análogos & derivados , Espectroscopía de Resonancia Magnética , Enfermedad de Pelizaeus-Merzbacher/diagnóstico , Adulto , Ácido Aspártico/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Diagnóstico Diferencial , Femenino , Eliminación de Gen , Duplicación de Gen , Humanos , Imagen por Resonancia Magnética , Masculino , Proteína Proteolipídica de la Mielina/genética , Enfermedad de Pelizaeus-Merzbacher/fisiopatología
17.
Neuropathology ; 20(4): 297-303, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11211054

RESUMEN

Whether the cerebral or subcortical lesions are involved in the pathogenesis in infantile spasms (IS) remains to be determined. To investigate the functional lesions of the subcortical structures in IS, the brainstem expression of neurotransmitters, neuropeptides and calcium-binding proteins in IS autopsy cases of lissencephaly and of perinatal hypoxic ischemic encephalopathy (HIE/IS) was investigated. The IS patients consisted of four subjects each of lissencephaly and HIE. They suffered from both West and Lennox-Gastaut syndromes. The healthy and disease controls were composed of four subjects without neuromuscular disorders and six cases of HIE (HIE/C), neither of whom had the epileptic syndrome. In these subjects the expressions of tryptophan hydroxylase (TrH), tyrosine hydroxylase (TH), parvalbumin (PV), methionine-enkephalin (ME) and substance P (SP) were immunohistochemically determined in serial sections of the midbrain, pons and medulla oblongata. The immunoreactivity of neurons and neuronal processes for TH was altered in the mesencephalic periaqueductal gray matter, locus ceruleus, and dorsal vagal nucleus in the patients. The HIE/IS cases showed reduced TrH-immunoreactivity in the medullary raphe nuclei. The brainstem auditory tract was poorly discernible on anti-PV immunostaining in the IS patients. The immunoreactivity for ME in the spinal trigeminal nucleus was severely affected in the IS patients, while that for SP was comparatively well preserved. It is suggested that the presence of common brainstem lesions in IS is irrespective of etiologies. It is intriguing that some of the changes seemed to be interrelated with the neurophysiological abnormalities being reported in IS patients.


Asunto(s)
Tronco Encefálico/patología , Proteínas de Unión al Calcio/análisis , Neuropéptidos/análisis , Neurotransmisores/análisis , Espasmos Infantiles/patología , Espasmos Infantiles/fisiopatología , Adolescente , Adulto , Tronco Encefálico/fisiopatología , Niño , Preescolar , Encefalina Metionina/análisis , Humanos , Inmunohistoquímica , Lactante , Neuronas/patología , Parvalbúminas/análisis , Sustancia P/análisis , Triptófano Hidroxilasa/análisis , Tirosina 3-Monooxigenasa/análisis
18.
J Vet Sci ; 1(1): 11-7, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-14612615

RESUMEN

To elucidate the role of nitric oxide synthase (NOS) in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), we analyzed the expression of constitutive neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS) in the spinal cords of rats with EAE. We further examined the structural interaction between apoptotic cells and spinal cord cells including neurons and astrocytes, which are potent cell types of nitric oxide (NO) production in the brain. Western blot analysis showed that three forms of NOS significantly increased in the spinal cords of rats at the peak stage of EAE, while small amounts of these enzymes were identified in the spinal cords of rats without EAE. Immunohistochemical study showed that the expression of either nNOS or eNOS increased in the brain cells including neurons and astrocytes during the peak and recovery stages of EAE, while the expression of iNOS was found mainly in the inflammatory macrophages in the perivascular EAE lesions. Double labeling showed that apoptotic cells had intimate contacts with either neurons or astrocytes, which are major cell types to express nNOS and eNOS constitutively. Our results suggest that the three NOS may play an important role in the recovery of EAE.


Asunto(s)
Encefalomielitis Autoinmune Experimental/enzimología , Óxido Nítrico Sintasa/metabolismo , Médula Espinal/enzimología , Animales , Apoptosis , Endotelio Vascular/enzimología , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Masculino , Óxido Nítrico Sintasa de Tipo I , Óxido Nítrico Sintasa de Tipo II , Óxido Nítrico Sintasa de Tipo III , Ratas , Ratas Endogámicas Lew , Médula Espinal/patología
19.
Eur J Neurosci ; 11(11): 4139-44, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10583502

RESUMEN

Recent studies have shown that hepatocyte growth factor (HGF) promotes the survival of embryonic motor neurons. However, it remains unclear whether HGF has trophic effects on mature motor neurons. In the present study, we examined the effects of HGF on adult motoneurons using the hypoglossal nerve transection model. In adult rats, neurons in the hypoglossal nucleus show a dramatic loss of choline acetyltransferase (ChAT) protein and mRNA after the axotomy. This reduction of ChAT was markedly prevented when HGF was administered continuously at the cut end of the nerve using an osmotic pump. The HGF receptor, c-met, protein and mRNA, which were faintly expressed in hypoglossal neurons under normal conditions, gradually increased and reached maximal levels 2 weeks after the axotomy. Administration of HGF reduced this c-met upregulation almost to normal levels. We also quantified HGF mRNA in the tongue and hypoglossal nucleus. The tongue contained abundant HGF mRNA, whereas the nucleus contained only low levels. Interestingly, the HGF mRNA level in the nucleus did not increase after the axotomy. These findings suggest that HGF is principally produced in the tongue and contributes to maintain ChAT expression in the nucleus. HGF produced in the hypoglossal nucleus alone after disconnection from the tongue may not be sufficient for the maintenance of the motor neuron function. Thus, exogenously applied HGF was effective to prevent the downregulation of ChAT activities. These findings provide a strong rationale for the potential clinical use of HGF for the treatment of motor neuron degenerative disease.


Asunto(s)
Factor de Crecimiento de Hepatocito/farmacología , Nervio Hipogloso/fisiología , Neuronas Motoras/fisiología , Factores de Crecimiento Nervioso/farmacología , Animales , Axotomía , Colina O-Acetiltransferasa/genética , Colina O-Acetiltransferasa/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Factor de Crecimiento de Hepatocito/administración & dosificación , Factor de Crecimiento de Hepatocito/genética , Infusiones Parenterales , Masculino , Bulbo Raquídeo/fisiología , Modelos Neurológicos , Neuronas Motoras/efectos de los fármacos , Proteínas Proto-Oncogénicas c-met/genética , ARN Mensajero/genética , Ratas , Ratas Endogámicas F344 , Lengua/fisiología , Transcripción Genética , Regulación hacia Arriba/efectos de los fármacos
20.
J Neuroimmunol ; 96(1): 66-72, 1999 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-10227425

RESUMEN

To characterize the nature of the alpha chain of TCR associated with the development of experimental autoimmune encephalomyelitis (EAE), spinal cord T cells isolated from individual rats with preclinical and clinical EAE were investigated by CDR3 spectratyping and subsequently, the amino acid sequences of the CDR3 region of oligoclonally expanded TCR determined. In contrast to the beta chain repertoire in which Vbeta8.2 with the shortest CDR3 is the predominant population throughout the course, multiple oligoclonal expansion was observed at all time points examined. Characteristically, Valpha1 and Valpha2 expansion was observed at preclinical and early stages, whereas that of Valpha8, Valpha13 and Valpha23 was detected at early and peak stages. Sequence analysis of the CDR3 region revealed that the former group possessed an asparagine repeat in the middle portion, whereas the latter group had the KLTF motif in the C terminal region of CDR3. These findings suggest that Valpha usage by EAE-associated T cells is stage-dependent and that EAE is induced by polyclonally activated T cells which switch TCR alpha chain, but not beta chain, phenotype as the disease progresses.


Asunto(s)
Complejo CD3/análisis , Encefalomielitis Autoinmune Experimental/inmunología , Médula Espinal/inmunología , Linfocitos T/química , Secuencia de Aminoácidos , Animales , Enfermedades Autoinmunes/inmunología , Complejo CD3/genética , Cartilla de ADN , ADN Complementario , Región Variable de Inmunoglobulina/inmunología , Inmunofenotipificación , Datos de Secuencia Molecular , Ratas , Ratas Endogámicas Lew , Médula Espinal/citología , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...